Question 1

What are the potential side effects of denikitug and zimberelimab?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Denikitug (GS-1811) Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors clinical trial (NCT05007782). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this trial compare to other treatment options available for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Denikitug (GS-1811) Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors clinical trial (NCT05007782). Contact the study team or your healthcare provider for specific answers.

Question 3

What is the expected duration of my participation in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Denikitug (GS-1811) Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors clinical trial (NCT05007782). Contact the study team or your healthcare provider for specific answers.

Question 4

Will I need to provide tumor tissue samples, and how will they be used?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Denikitug (GS-1811) Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors clinical trial (NCT05007782). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Denikitug (GS-1811) Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors clinical trial (NCT05007782). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any travel or logistical considerations I should be aware of for participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Denikitug (GS-1811) Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors clinical trial (NCT05007782). Contact the study team or your healthcare provider for specific answers.

What this study is about